Curevac Stock Analysis

CVAC -  USA Stock  

USD 18.38  0.16  0.88%

The big decline in price over the last few months for Curevac NV could raise concerns from investors as the firm it trading at a share price of 18.38 on 798,500 in volume. The company management teams failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Curevac NV or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.96. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Curevac NV partners.
Continue to Trending Equities.

Curevac Stock Analysis 

The Curevac NV stock analysis report makes it easy to digest most publicly released information about Curevac NV and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Curevac Stock analysis module also helps to analyze the Curevac NV price relationship with some important fundamental indicators such as market cap and management efficiency.

Curevac Stock Analysis Notes

About 55.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 0.07. Curevac NV recorded a loss per share of 2.87. The entity had not issued any dividends in recent years. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid . The company was founded in 2000 and is headquartered in Tbingen, Germany. Curevac NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 455 people. For more info on Curevac NV please contact the company at 49 7071 9883 0 or go to

Curevac NV Quarterly Deferred Revenue

746.55 MillionShare

Curevac NV Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Curevac NV's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Curevac NV or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Curevac NV generated a negative expected return over the last 90 days
Curevac NV has high historical volatility and very poor performance
The company reported the previous year's revenue of 67.81 M. Net Loss for the year was (467.93 M) with profit before overhead, payroll, taxes, and interest of 34.75 M.
Curevac NV currently holds about 1.33 B in cash with (108.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.09.
Roughly 55.0% of the company shares are held by company insiders
Latest headline from Moderna Rout Continues as Haven Plays Replace Vaccine Names - Bloomberg

Curevac NV Upcoming and Recent Events

Earnings reports are used by Curevac NV to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Curevac NV previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report26th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End26th of April 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Curevac NV SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Curevac NV prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Curevac NV investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Curevac NV specific information freely available to individual and institutional investors to make a timely investment decision.
18th of January 2022
Other Events
13th of January 2022
Other Events. Unclassified Corporate Event
7th of January 2022
Other Events
3rd of January 2022
Other Events
17th of December 2021
Other Events
18th of November 2021
Other Events
10th of November 2021
Other Events
18th of October 2021
Unclassified Corporate Event

Curevac Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 3.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Curevac NV's market, we take the total number of its shares issued and multiply it by Curevac NV's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Curevac Profitablity

Curevac NV's profitability indicators refer to fundamental financial ratios that showcase Curevac NV's ability to generate income relative to its revenue or operating costs. If, let's say, Curevac NV is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Curevac NV's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Curevac NV's profitability requires more research than a typical breakdown of Curevac NV's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.18) (0.19) 
Return on Average Equity(0.35) (0.36) 
Return on Invested Capital(1.52) (1.64) 
Return on Sales(2.54) (2.74) 

Management Efficiency

The entity has return on total asset (ROA) of (24.68) % which means that it has lost $24.68 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (64.25) %, meaning that it created substantial loss on money invested by shareholders. Curevac NV management efficiency ratios could be used to measure how well curevac nv manages its routine affairs as well as how well it operates its assets and liabilities. As of January 26, 2022, Return on Average Assets is expected to decline to -0.19. In addition to that, Return on Average Equity is expected to decline to -0.36. Curevac NV Total Assets are projected to increase significantly based on the last few years of reporting. The past year's Total Assets were at 1.74 Billion. The current year Current Assets is expected to grow to about 1.7 B, whereas Assets Non Current are forecasted to decline to about 121.3 M.
Last ReportedProjected for 2022
Book Value per Share 4.64  5.01 
Enterprise Value over EBIT(90.90) (98.07) 
Enterprise Value over EBITDA(100.96) (108.93) 
Price to Book Value 14.84  14.75 
Tangible Assets Book Value per Share 9.76  7.80 
Enterprise Value12 B11.9 B
Tangible Asset Value1.7 B1.9 B

Technical Drivers

As of the 26th of January, Curevac NV shows the risk adjusted performance of (0.17), and Mean Deviation of 3.76. Curevac NV technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Curevac NV, which can be compared to its rivals. Please confirm Curevac NV value at risk, expected short fall, and the relationship between the treynor ratio and downside variance to decide if Curevac NV is priced correctly, providing market reflects its regular price of 18.38 per share. Given that Curevac NV has jensen alpha of (1.05), we suggest you to validate Curevac NV's prevailing market performance to make sure the company can sustain itself at a future point.

Curevac NV Price Movement Analysis

The output start index for this execution was one with a total number of output elements of sixty. The Simple Moving Average indicator is calculated by adding the closing price of Curevac NV for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Curevac NV short-term fluctuations and highlight longer-term trends or cycles. View also all equity analysis or get more info about simple moving average overlap studies indicator.

Curevac NV Predictive Daily Indicators

Curevac NV intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Curevac NV stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Curevac NV Forecast Models

Curevac NV time-series forecasting models is one of many Curevac NV's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Curevac NV's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Curevac Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Curevac NV stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Curevac shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Curevac NV. By using and applying Curevac Stock analysis, traders can create a robust methodology for identifying Curevac entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(2.28) (2.46) 
Gross Margin 0.82  0.88 
Profit Margin(3.04) (3.28) 
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid . The company was founded in 2000 and is headquartered in Tbingen, Germany. Curevac NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 455 people.

Current Curevac Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Curevac analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Curevac analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Curevac NV current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Curevac analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Curevac stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Curevac NV, talking to its executives and customers, or listening to Curevac conference calls.
Curevac Analyst Advice Details

Curevac Stock Analysis Indicators

Curevac NV stock analysis indicators help investors evaluate how Curevac NV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Curevac NV shares will generate the highest return on investment. By understating and applying Curevac NV stock analysis, traders can identify Curevac NV position entry and exit signals to maximize returns.
Quick Ratio1.45
Fifty Two Week Low18.56
Revenue Growth-11.40%
Shares Short Prior Month4.07M
Average Daily Volume Last 10 Day931.56k
Average Daily Volume In Three Month717.03k
Shares Percent Shares Out1.90%
Gross Margins-158.46%
Short Percent Of Float4.65%
Forward Price Earnings-12.01
Float Shares77.18M
Fifty Two Week High133.00
Enterprise Value To Ebitda-9.70
Fifty Day Average36.12
Two Hundred Day Average63.30
Enterprise Value To Revenue74.40
Continue to Trending Equities. Note that the Curevac NV information on this page should be used as a complementary analysis to other Curevac NV's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Curevac Stock analysis

When running Curevac NV price analysis, check to measure Curevac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curevac NV is operating at the current time. Most of Curevac NV's value examination focuses on studying past and present price action to predict the probability of Curevac NV's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Curevac NV's price. Additionally, you may evaluate how the addition of Curevac NV to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Transaction History
View history of all your transactions and understand their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Curevac NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Curevac NV. If investors know Curevac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Curevac NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Curevac NV is measured differently than its book value, which is the value of Curevac that is recorded on the company's balance sheet. Investors also form their own opinion of Curevac NV's value that differs from its market value or its book value, called intrinsic value, which is Curevac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Curevac NV's market value can be influenced by many factors that don't directly affect Curevac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Curevac NV's value and its price as these two are different measures arrived at by different means. Investors typically determine Curevac NV value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Curevac NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.